Theoretical and Natural Science

- The Open Access Proceedings Series for Conferences


Theoretical and Natural Science

Vol. 23, 20 December 2023


Open Access | Article

Review of the applicability of the DASH diet for patients with chronic kidney disease and chronic liver disease

Xiyuan Zhu * 1
1 Colgate University

* Author to whom correspondence should be addressed.

Theoretical and Natural Science, Vol. 23, 108-111
Published 20 December 2023. © 2023 The Author(s). Published by EWA Publishing
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citation Xiyuan Zhu. Review of the applicability of the DASH diet for patients with chronic kidney disease and chronic liver disease. TNS (2023) Vol. 23: 108-111. DOI: 10.54254/2753-8818/23/20231034.

Abstract

Hypertension is a significant risk factor for cardiovascular diseases, and the DASH diet effectively lowers blood pressure. However, individuals with Chronic Kidney Disease (CKD) and Chronic Liver Disease (CLD) need adaptations in potassium and sodium/water intake to adhere to the DASH diet. This literature review examines the applicability of the DASH diet for patients with CKD and CLD by analyzing findings from a comprehensive search of relevant academic databases. The review explores various sources, including clinical studies, research articles, and expert recommendations, to assess the effectiveness and suitability of the DASH diet in managing the dietary needs of individuals with CKD and CLD. The review reveals that the DASH diet, with its emphasis on reduced sodium intake and increased consumption of fruits, vegetables, whole grains, and lean proteins, shows promising results in managing blood pressure and improving overall cardiovascular health in individuals with early stage CKD and CLD. Furthermore, the review concludes that individuals with advanced CKD and CLD should exercise caution when considering the DASH diet, as modifications are necessary to accommodate their specific conditions. For patients with advanced CKD, careful management of potassium intake is essential to prevent hyperkalemia; while individuals with late-stage CLD should monitor both sodium and water intake to avoid dilutional hyponatremia. Additionally, the review also emphasized the importance of individualized dietary modifications and consultations with healthcare professionals for optimizing the benefits of the DASH diet, especially for those patients with later stages of CKD and CLD.

Keywords

hypertension, DASH diet, excessive sodium intake, chronic kidney disease (CKD), chronic liver disease (CLD)

References

1. Sun, N., Jiang, Y., Wang, H., Yuan, Y., Cheng, W., Han, Q., Yuan, H., Yang, L., Guo, Z., Sun, Y., Sun, G., Yin, X., Wang, H., Mu, J., & Wang, J. (2021). Survey on sodium and potassium intake in patients with hypertension in China. The Journal of Clinical Hypertension, 23(11), 1957–1964.

2. DASH Eating Plan | NHLBI, NIH. (n.d.). Www.nhlbi.nih.gov. https://www.nhlbi.nih.gov/ education/dash-eating-plan#:~:text=DASH%20(Dietary%20Approaches%20to%20Stop

3. Harvard School of Public Health. (2018, January 16). Diet Review: DASH. The Nutrition Source. https://www.hsph.harvard.edu/nutritionsource/healthy-weight/diet-reviews/dash-diet/

4. Levey, A. S., & Coresh, J. (2012). Chronic kidney disease. The Lancet, 379(9811), 165–180.

5. Picard, K., Barreto Silva, M. I., Mager, D., & Richard, C. (2020). Dietary Potassium Intake and Risk of Chronic Kidney Disease Progression in Predialysis Patients with Chronic Kidney Disease: A Systematic Review. Advances in Nutrition, 11(4), 1002–1015.

6. Tyson, C. C., Lin, P.-H., Corsino, L., Batch, B. C., Allen, J., Sapp, S., Barnhart, H., Nwankwo, C., Burroughs, J., & Svetkey, L. P. (2016). Short-term effects of the DASH diet in adults with moderate chronic kidney disease: a pilot feeding study. Clinical Kidney Journal, 9(4), 592–598.

7. Alcázar Arroyo, R., Orte Martínez, L., & Otero González, A. (2008). Advanced chronic kidney disease. Nefrologia: Publicacion Oficial de La Sociedad Espanola Nefrologia, 28 Suppl 3, 3–6.

8. Kidney Disease Outcomes Quality Initiative (K/DOQI). (2004). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation, 43(5 Suppl 1), S1-290.

9. Sharma, A., & Nagalli, S. (2022). Chronic Liver Disease. PubMed; StatPearls Publishing.

10. What Are The Four Stages of Liver Disease. (2021, October 18). Orlando Clinical Research Center. https://ocrc.net/what-are-the-four-stages-of-liver-disease/

11. Mansour, D., & McPherson, S. (2018). Management of decompensated cirrhosis. Clinical Medicine, 18(Suppl 2), s60–s65.

12. Harvard School of Public Health. (2019, September 24). Water. The Nutrition Source. https://www.hsph.harvard.edu/nutritionsource/water/

13. Pedersen, J. S., Bendtsen, F., & Møller, S. (2015). Management of cirrhotic ascites. Therapeutic Advances in Chronic Disease, 6(3), 124–137.

14. National Institute of Diabetes and Digestive and Kidney Diseases. (2019, September 18). Nutrition for Advanced Chronic Kidney Disease in Adults | NIDDK. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/eating-nutrition/nutrition-advanced-chronic-kidney-disease-adults

Data Availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:

1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.

3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).

Volume Title
Proceedings of the 3rd International Conference on Biological Engineering and Medical Science
ISBN (Print)
978-1-83558-219-0
ISBN (Online)
978-1-83558-220-6
Published Date
20 December 2023
Series
Theoretical and Natural Science
ISSN (Print)
2753-8818
ISSN (Online)
2753-8826
DOI
10.54254/2753-8818/23/20231034
Copyright
20 December 2023
Open Access
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Copyright © 2023 EWA Publishing. Unless Otherwise Stated